CELL & gene THERAPY steering committee
Mission
To build and advance the supply chain of this nascent medical science by
- promoting collaboration among the emerging stakeholders;
- creating a platform for exchange of business knowledge and experience;
- fostering commercialization and scaling up of CAR-T Cell Therapy;
- incorporating agility, accountability, quality and integrity in the business end-to-end;
- and enabling the delivery of affordable healthcare in the long run.
The Supply Chain challenges are truly Draconian with the production batch size of one, where the environment of temperature control, chain of custody, overall product and process integrity, and reliability of supply of manufacturing materials is demanding. It is an unprecedented challenge for science and business to come together.
Chairperson

Devendra Mishra
Executive Director, BSMA

Heather Erickson
Vice President, Global Supply Chain, Sangamo

Dr. Alison Moore
CTO, Allogene Therapeutics

Bernard Huyghe
Director, External Supply, Allogene Therapeutics

Matthew Yedwabnick, Sr.
Director Supply Chain, Atara Biotherapeutics

Franck Toussaint
Managing Director, Biolog Europe

Kenneth Locke
Vice President, Manufacturing, Carisma Therapeutics

Kimberly Foster
Scientific Director, Bristol Myers Squibb

David Karakas
Director, Procurement & Sourcing, Bluebird Bio

Jayant Aphale
Former Executive Vice President of Technical Operations, Gritstone Oncology

Neil Ackerman
Senior Director, Enterprise Supply Chain Global Planning and Innovation, Johnson and Johnson

Deidre Hobbs
Senior Director, Quality, Kite Pharma

Howard Bland, Sr.
Director, Sourcing & Procurement, Kite Pharma

Sophia-Donaldson
Head Global Strategic Sourcing, Kite Pharma

Reggie Foster
Director Logistics and Packaging Engineering, Kite Pharma

Kirstin Powell
Vice President Quality Assurance, Talaris

Peter Holman
Global Apheresis Integration, Novartis

Ran Zheng
Former CTO, Orchard Therapeutics

Heather Steinmetz
QA Manager for Bone Marrow Transplant, UCLA

Robert Bottome
Vice President, Global Supply Chain, BioMarin

Aileen Baquiran
Vice President, Global Supply Chain, Orchard Therapeutics

Jon Miller
Director, Head of Supply Chain, PACT Pharma

Mandar Paralkar, Sr.
Director and Digital Innovation Advisor of Life Sciences, SAP

Jon Pieter Kapelle
Vice President of Strategy, 4G Clinical

Kevin Cast
Partner, Archbow Consulting (Omnicom Health Group)

Paul Furgal
Vice President, Archbow Consulting (Omnicom Health Group)

Greg Bodnar, Sr.
Manager, Client Engagement, BeTheMatch

Bob Lamont
Partner, Clark Consulting

Guy Carlo
Vice President and GM, ThermoFisher Scientific

Carla Reed
CEO, New Creed

Chris Bogart
Vice President of Supply Chain, Bayer Healthcare
2019 Conference Documents
Notes from 0814 Meeting
OPERATIONS–THE GATEWAY TO SUCCESS IN CELL AND GENE THERAPIES
Navigating the Unique Manufacturing Challenges in Cell and Gene Therapy
Commercial Considerations for Planning a Successful Cell and Gene Therapy Product Launch
Overcoming Complexities of the Personalized Medicine Supply Chain
2018 Conference Documents